Skip to main content

Peer Review reports

From: A pilot study of multi-antigen stimulated cell therapy-I plus camrelizumab and apatinib in patients with advanced bone and soft-tissue sarcomas

Original Submission
19 Apr 2023 Submitted Original manuscript
13 Jul 2023 Reviewed Reviewer Report
15 Aug 2023 Reviewed Reviewer Report
15 Aug 2023 Reviewed Reviewer Report
20 Sep 2023 Author responded Author comments - Yan Zhou
Resubmission - Version 2
20 Sep 2023 Submitted Manuscript version 2
20 Sep 2023 Reviewed Reviewer Report
20 Sep 2023 Reviewed Reviewer Report
22 Sep 2023 Reviewed Reviewer Report
24 Oct 2023 Author responded Author comments - Yan Zhou
Resubmission - Version 3
24 Oct 2023 Submitted Manuscript version 3
Publishing
25 Oct 2023 Editorially accepted
29 Nov 2023 Article published 10.1186/s12916-023-03132-x

You can find further information about peer review here.

Back to article page